Besides the antinociceptive effect of A3AR agonists in cancer pain and neuropathic pain related to chemotherapy, they have also found to be potent antitumoral agents in many animal models of different forms of cancer (melanoma, prostate, colon, and hepatocellular carcinoma), where they are able to reduce tumor growth [113,125]. Here, ADORA3 is linked to cancer.